Listing & Compliance Notices

GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 17, 2023, First Wave BioPharma, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of $881,960 as reported in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2023 was below the required minimum of $2.5 million, and because, as of June 30, 2023, the Comp”

CONTRAFECT Corp received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 15, 2023, the Nasdaq staff (“Staff”) informed the Company that, based on the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023, the Company did not meet the Minimum Stockholders’ Equity Requirement or any other alternatives available for continued listing on the Nasdaq Capital Market and therefore the Staff had determined to delist the Company’s common stock from the Nasdaq Capital Market (the “Staff Determination”). As a result of the Mandatory Panel Monitor described in the July 21, 2023 notice from Nasdaq, the Company is not eligible for a complianc”

Cuentas Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“ntas Inc.(Nasdaq: CUEN) (“the “Company”) received a deficiency letter from Nasdaq Regulation stating that based upon its Quarterly Report on Form 10-Q for the period ended June 30, 2023 which reported shareholders’ equity of $1,471,000, the Company was not in compliance with Nasdaq Marketplace Rule 5550(b)(1) which requires the Company to maintain shareholders’ equity of not less than $2,500,000 for continued listing on The Nasdaq Capital Market. Under Nasdaq Rules the Company has until October 2, 2023 (45 calendar days) to submit a plan to regain compliance. If its plan is accepted, Nasdaq ca”

Edgio, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 14, 2023, Edgio, Inc. (“Edgio” or the “Company”) received a notification letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), and because the Company remained delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the “Q1 Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires Nasd”

Veradigm Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“August 16, 2023, the Company received an additional notice (the “Additional Notice”) from Nasdaq stating that, because the Company has not filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Q2 Form 10-Q”, and together with the Q1 Form 10-Q, the “Form 10-Qs”), and because the Company remains delinquent in filing the Form 10-K and the Q1 Form 10-Q, the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rules”). On May 18, 2023, the Company submitted to Nasdaq its compliance plan (the “Compliance Plan”) addressing both the Form 10-K and F”

DZS INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 15, 2023, DZS Inc. (the “Company”) received a delinquency notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Form 10-Q”), the Company is not in compliance with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1). The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. The Company filed”

REPUBLIC FIRST BANCORP INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 11, 2023, The Nasdaq Stock Market LLC (“Nasdaq”) notified Republic First Bancorp, Inc. (the “Company”) that because the Company’s Form 10-Q for the three months ended June 30, 2023 (the “Form 10-Q”) was not timely filed with the Securities and Exchange Commission (the “SEC”), the Company does not satisfy Nasdaq Listing Rule 5250(c)(1) (the “Filing Requirement”) and that the Nasdaq Hearings Panel (the “Panel”) would consider the additional deficiency in its deliberations regarding the Company’s continued listing. The Company intends to present its plan to file the Form 10-Q with the SEC”

MITEK SYSTEMS INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 14, 2023, Mitek Systems, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), as expected, advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Q3 Form 10-Q”) in a timely manner and that such matter serves as an additional basis for delisting the Company’s securities from Nasdaq. The Rule requires”

Chenghe Acquisition I Co. received a nasdaq delisting notice notice regarding market value (rules 5452(b)(C)).

“GW” (the “Warrants”), from NASDAQ and that trading in the Warrants would be suspended at the opening of business on August 25, 2023, due to the Company’s failure to maintain a minimum of $1,000,000 in aggregate market value of its outstanding warrants for continued listing under NASDAQ Listing Rule 5452(b)(C). While the Company may appeal the Staff’s delisting determination by August 23, 2023, it does not intend to request an appeal. As a result, a Form 25-NSE will be filed by NASDAQ with the Securities and Exchange Commission (the “SEC”) to remove the Company’s securities from listing and reg”

PaxMedica, Inc. received a nasdaq extension granted notice regarding market value (rules 5550(b)(2), 5550(b)(1)).

“August 16, 2023, PaxMedica, Inc. (the “ Company ”) received a decision from the Hearings Panel (the “ Panel ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) granting the Company’s request for an exception to maintain its listing on The Nasdaq Capital Market notwithstanding its failure to regain compliance with Nasdaq Listing Rule 5550(b)(2) (the “ Minimum Market Value Requirement ”), requiring the Company to maintain a market value of listed securities of a minimum of $35 million. The Company’s request was granted, subject to the Company demonstrating compliance, on or prior to December 11, 2023”

Akebia Therapeutics, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 11, 2023, Akebia Therapeutics, Inc. (the “Company”) received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that since it has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “Quarterly Report”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“SEC”). The Nasdaq notification letter specifies that the Company has 60 calendar days”

MITEK SYSTEMS INC received a nasdaq hearing update notice regarding other.

“July 5, 2023, the Company received a notice from the Panel notifying the Company that the Panel granted the Company’s request to extend the automatic stay of suspension from Nasdaq pending the Company’s hearing before the Panel scheduled for August 10, 2023, and a final determination regarding the Company’s listing status. On August 10, 2023, the Company presented its plan to regain compliance with the Rule to the Panel and expects to receive a decision from the Panel regarding the Company’s request for continued listing on Nasdaq in late August or September. Given that the Company addressed i”

MITEK SYSTEMS INC received a nasdaq deficiency notice notice regarding other (rules 5250(c)(1)).

“August 14, 2023, Mitek Systems, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), as expected, advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Q3 Form 10-Q”) in a timely manner and that such matter serves as an additional basis for delisting the Company’s securities from Nasdaq. The Rule requires”

Polished.com Inc. received a nyse_american delisting notice notice regarding other (rules 1001).

“the Company’s Warrants has no impact with respect to trading of the Company’s common stock (ticker symbol POL), which will continue on the NYSE American. The Staff justified its determination to commence proceedings to delist the Warrants because they are no longer suitable for listing pursuant to Section 1001 of the NYSE American Company Guide due to the low trading price of the Warrants. The Company has a right to a review of the Staff’s determination by a Committee of the Board of Directors of the NYSE American and intends to appeal such determination. The NYSE American will apply to the S”

DATASEA INC. received a nasdaq extension granted notice regarding market value (rules 5550(b)(2)).

“f Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed on a Current Report on Form 8-K filed on June 13, 2023, the Company received a letter from Nasdaq indicating that the Company had not regained compliance with the Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). On August 3, 2023, the Company appeared before a Nasdaq hearing panel and requested for additional time to regain compliance with the MVLS Requirement. On August 11, 2023, Nasdaq issued a letter to the Company, granting an extension to regain compliance with the”

BIOLASE, INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5815(d)(4)(B), 5550(a)(2), 5810(c)(2), 5810(c)(3), 5815(d)(4)(C)).

“August 14, 2023, BIOLASE, Inc. (the “Company”) received a letter (the “Letter”) from the Nasdaq Office of General Counsel confirming the decision of the Nasdaq Stock Market LLC (“Nasdaq”) Hearings Panel (the “Panel”), that the Company currently demonstrates compliance with the requirements for continued listing on The Nasdaq Capital Market. According to the Letter, pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of this letter. If, within that one-year monitoring period, the Listing Qualifications st”

HWH International Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(1)(B)).

“August 9, 2023, Alset Capital Acquisition Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that, under the Nasdaq Listing Rules (the “Nasdaq Rules”), specifically, Nasdaq Rule 5450(b)(1)(B), “Companies listed on The Nasdaq Global Market are required to maintain a minimum of 1,100,000 publicly held shares for continued listing.” The Company has previously disclosed that based on the number of Class A common shares to be redeemed (unless such redemptions are cancelled) that it would have 41,287 publicly he”

Liberty Resources Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5450(b)(1)(B), 5450(b)(2)(B)).

“June 15, 2023 notifying the Company that it no longer met the minimum 1,100,000 publicly held shares required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5450(b)(1)(B) (the “ Public Float Standard ”) and providing the Company 45 calendar days to submit a plan to regain compliance. The Company submitted a compliance plan for the Public Float Standard (the “ Compliance Plan ”) on July 28, 2023. On August 14, 2023, Nasdaq sent to the Company written notice confirming Nasdaq’s grant to the Company of an extension to regain compliance with Listing Rule 5450(b)(2)(B). On or befor”

Ontrak, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1), 5550(b)).

“August 15, 2023, Ontrak, Inc. (the “Company,” “we,” “us,” or “our”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that because it reported less than $2.5 million in stockholders’ equity as of June 30, 2023, which is the minimum amount required under Nasdaq Listing Rule 5550(b)(1) for continued listing on the Nasdaq Capital Market (the “Stockholders’ Equity Requirement”), and it did not satisfy the alternative continued listing standards, the Company no longer complies with Nasdaq Listing Rule 5550(b). The S”

Freedom Holding Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 11, 2023, Freedom Holding Corp. (the “Company”) received a letter (the “Non-Compliance Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Nasdaq Listing Rule") as a result of its failure to have timely filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “June 2023 10-Q”). The Non-Compliance Letter provides that, under Nasdaq rules, the Company now has 60 calendar days, or until October 10, 2023, to submit to Nasdaq a plan to regain”

Alternus Clean Energy, Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5452(b)(C)).

“June 13, 2023, Clean Earth Acquisitions Corp. (the “Company”) received a letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (the “Staff”) notifying the Company that the $575,000.00 aggregate market value of the Company’s outstanding public warrants, ticker symbol CLINW, as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023, was below the minimum aggregate market value of $1,000,000.00 required for continued listing on the Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5452(b)(C) (the “Rule”

Applied Molecular Transport Inc. received a nasdaq delisting notice notice regarding other (rules 5100, 5450(a)(1)).

“August 10, 2023, Applied Molecular Transport Inc. (the “ Company ”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (the “ Staff ”) indicating that, in accordance with The Nasdaq Stock Market LLC’s (“ Nasdaq ”) Listing Rule 5100, the Staff believes the Company is a “public shell” and that the continued listing of the Company’s securities is no longer warranted. The Company disagrees with the Staff’s determination and intends to timely appeal the Staff’s determination to Nasdaq’s Hearings Panel (“ Panel ”), which will stay any delisting action by the Staff”

ID Auto, Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

“August 8, 2023, the Company received a letter from the Exchange notifying the Company that the Plan was accepted. The Exchange has granted the Company a plan period through November 23, 2024 to regain compliance with the continued listing standards. If the Company is not in compliance with the continued listing standards by that date or if the Company does not make progress consistent with the Plan during the plan period, the Exchange may commence delisting procedures. The Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”) will continue to be listed on the Exchang”

Exela Technologies, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 11, 2023, the Company received a notice of non-compliance from Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). Under Nasdaq’s listing rules, the Company has 60 calendar days to submit a plan to regain comp”

CYANOTECH CORP received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“August 10, 2023, Cyanotech Corporation (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5550(a)(2) (“Bid Price Rule”). The Notice provided that, in accordance with the Nasdaq Listing Rule 5810(c)(3)(A) (the Compliance Period Rule), the Company has an in”

Senti Biosciences, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“August 7, 2023, Senti Biosciences, Inc. (the “ Company ” or “ Senti Bio ”) received written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, for the last 30 consecutive trading days, the closing bid price of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), had closed below the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “ Minimum Bid Price Requirement ”). The Notice has no”

Fintech Ecosystem Development Corp. received a nasdaq deficiency notice notice regarding shareholders.

“August 10, 2023, the Company received a letter from the Staff of the Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC, stating that the Staff has determined that the Company has not complied with the requirements of the Nasdaq Listing Rules because the Company has not demonstrated that its securities comply with the minimum 400 Total Holder requirement. The letter from the Staff indicated that the Company has until September 25, 2023 to submit a plan to regain compliance. If Nasdaq does not accept the plan, the Company will have the opportunity to appeal the dec”

REVELATION BIOSCIENCES, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 8, 2023, Revelation Biosciences, Inc. (the “Company”) received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by failing to maintain a minimum bid price for its common stock of at least $1.00 per share for 30 consecutive business days. According to the letter, the Company has a 180 calendar day grace period to regain compliance with the Rule (the “Grace Period”), subject to a potential 180 calendar day extension, as described below. To regain compliance, the Company’s common stock must have”

DATASEA INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“price of the Company’s common stock (“Common Stock”) for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). The Notice has no immediate effect on the continued listing status of the Company’s Common Stock on the Nasdaq Capital Market, and, therefore, the Company’s listing remains fully effective. However, the Company is provided a compliance period of 180 calend”

AMYRIS, INC. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“August 10, 2023, Amyris, Inc. (the “Company”) and certain of its direct and indirect subsidiaries filed a voluntary petition for relief (the “Chapter 11 Cases”) under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. On August 10, 2023, the Company received written notice (the “Delisting Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Chapter 11 Cases and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq had determined that the C”

NeuroMetrix, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“August 8, 2023, NeuroMetrix, Inc. (the “Company”) received a notice from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The notice states that pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company will be afforded 180 calendar days, or until February 5, 2024, to regain compliance with the minimum bid price require”

EVgo Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605).

“August 8, 2023, the Company received a written notice (the “ Letter ”) from Nasdaq’s Listing Qualifications Department confirming that, as a result of Mr. Badar Khan’s departure from the Audit Committee, the Company is no longer in compliance with Nasdaq’s audit committee composition requirement set forth in Nasdaq Listing Rule 5605. The Letter is only a notification of deficiency and has no current effect on the listing or trading of the Company’s securities on Nasdaq. The Letter states that, consistent with Nasdaq Listing Rule 5605(c)(4), Nasdaq will provide the Company with a cure period in”

NEXTNRG, INC. received a nasdaq noncompliance notice notice regarding board independence (rules 5605).

“August 8, 2023, the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to the previously disclosed resignations of Allen Weiss, Luis Reyes, Mark Lev, and Jack Levine from the Company’s Board of Directors (the “Board”), the Company, effective July 28, 2023, is not in compliance with Nasdaq’s majority independent board and independent audit, compensation, and nominating committee requirements as set forth in Listing Rule 5605. The Company will have until September 22, 2023 to submit a plan”

Benitec Biopharma Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“August 9, 2023, the Company received written notice from the Listing Qualifications Department of Nasdaq informing the Company that it has regained compliance with the Bid Price Rule based on the closing price of the Company’s common stock having been at $1.00 per share or greater for 10 consecutive trading days and that the matter is now closed. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BENITEC BIOPHARMA INC. Date: August 10, 2023 /s/ Jerel”

Innovative Eyewear Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“August 4, 2023, Innovative Eyewear, Inc., a Florida corporation (the “ Company ”), received a written notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2). which sets forth the minimum bid price requirement for continued listing on the Nasdaq Capital Market (the “ Minimum Bid Requirement ”) as the bid price of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), had closed below $1.00 per share for 30 consecuti”

micromobility.com Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).

“August 4, 2023, we received a Staff Delisting Determination letter from the Nasdaq Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq"), advising us that as of August 4, 2023, our class A common stock had a closing bid price of $0.10 or less for at least ten consecutive trading days and is subject to Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the "Low Price Stocks Rule"). Accordingly, unless we request an appeal of this Staff Delisting Determination, the Staff has advised us that our class A common stock will be scheduled for delisting from The Nasdaq Capital”

Aclarion, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 4, 2023, Aclarion, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per”

Yellow Corp received a nasdaq delisting notice notice regarding other (rules 101, 5110(b), IM-5101-1).

“August 7, 2023, the Company was notified by the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that it commenced proceedings to delist the common stock of the Company, par value $0.01 (the “Common Stock”) pursuant to Nasdaq Listing Rules 101, 5110(b) and IM-5101-1, and has determined that the Common Stock will be delisted from the Nasdaq due to the Company’s filing of a voluntary cases under Chapter 11 of the Bankruptcy Code. The Company does not intend to appeal the determination and, therefore, it is expected that its Common Stock will be delisted, which”

Trump Media & Technology Group Corp. received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1)).

“August 7, 2023, the Company received a notice from Nasdaq stating that Nasdaq has determined to grant an exception to enable the Company to regain compliance with the Rule. The terms of the exception are as follows: on or before November 20, 2023, the Company must file its amended Annual Report on Form 10-K for the year ended December 31, 2022 and its Q1 Form 10-Q, as required by the Rule. In the event the Company does not satisfy the terms of the exception, Nasdaq will provide written notification that the Company’s securities will be delisted. At that time, the Company may appeal Nasdaq’s de”

Latch, Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“August 8, 2023, the Company received a notice from the Panel stating that it has determined to suspend trading of the Company’s securities on August 10, 2023 and commence delisting procedures because of the Company’s failure to regain compliance with the Listing Rule by the Deadline. Following the suspension of trading in the Company’s securities on Nasdaq, the Company expects that its securities will be traded on the OTC Expert Market. The Company had previously received notices from Nasdaq (i) on August 11, 2022, November 14, 2022 and May 16, 2023 regarding the Company’s failure to file its”

ABVC BIOPHARMA, INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“August 8, 2023, the Company received a notification letter (the “ Notification Letter ”) from Nasdaq notifying the Company that the Staff has determined that for 10 consecutive business days, from July 25, 2023 to August 7, 2023, the closing bid price of the Company’s common stock has been at least $1.00 per share or greater. Accordingly, the Staff has determined that the Company has regained compliance with Listing Rule 5550(a)(2) and has indicated that the matter is now closed. On August 10, 2023, the Company shall issue a press release announcing that the Company received the Notification L”

Zivo Bioscience, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)).

“August 4, 2023, the Company received a notification letter from the Nasdaq notifying the Company that the Panel has granted the Company’s request to provide an extension until November 20, 2023 (the “Exception Period”), to regain compliance with the Stockholders’ Equity Rule for continued listing on Nasdaq. The Panel further noted that the Exception Period for continued listing is subject to a filing of a registration statement on Form S-1 by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on or before October 5, 2023. The Panel concluded that the Exception Period is”

SharpLink Gaming Ltd. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“equity of at least $2,500,000 under the equity standard. Because the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023 reported stockholders’ equity of $1,489,034, and as of May 22, 2023 the Company does not meet the alternative standards for market value of listed securities or net income from continuing operations, the Company no longer”

Future Health ESG Corp. received a nasdaq extension granted notice regarding other (rules 5550(a)(3)).

“August 7, 2023, the Company received a written notice (the “Extension Notice”) from Nasdaq notifying the Company that Nasdaq had determined to grant the Company an extension until November 28, 2023 to regain compliance with the Minimum Public Holders Rule. In the event the Company does not satisfy the terms of the Extension Notice, Nasdaq will provide written notification that the Company’s securities will be delisted. At that time, the Company may appeal Nasdaq’s determination to a Listing Qualifications Panel. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the”

Marblegate Acquisition Corp. received a nasdaq compliance regained notice regarding shareholders (rules 5450(a)(2)).

“August 2, 2023, Marblegate Acquisition Corp. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, based on the materials submitted by the Company in connection with its application to transfer its listing to The Nasdaq Capital Market, the Staff has determined that the Company has regained compliance with the minimum 400 total holders requirement for The Nasdaq Global Market set forth in Listing Rule 5450(a)(2). Accordingly, the Staff has indicated that the”

Proterra Inc received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“August 8, 2023, the Company received written notice (the “Delisting Notice”) from the listing qualifications department staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, in accordance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1, the staff of Nasdaq has determined that the Company’s securities will be delisted from Nasdaq. In the Delisting Notice, the staff of Nasdaq referenced the Chapter 11 filing and associated public interest concerns raised by it, concerns regarding the residual equity interest of the existing listed securities holders, and concerns abo”

AIRWA INC. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“August 2, 2023, Connexa Sports Technologies Inc. (the “ Company ”) received a letter (“ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company’s failure to file its Annual Report on Form 10-K for the year ended April 30, 2023 (the “ Form 10-K ”), in violation of the Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), serves as an additional basis for delisting the Company’s securities from Nasdaq based on Listing Rule 5810(b). According to the Letter, the Nasdaq Hearings Panel (the “”

MetaVia Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 8, 2023, NeuroBo Pharmaceuticals, Inc. (the “Company” ) received a letter (the “Notice” ) from the Listing Qualifications Department (the “Staff” ) of the Nasdaq Stock Market ( “Nasdaq” ) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement” ). In accordance with Nasdaq Listing Rule”

Avalo Therapeutics, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“August 8, 2023, Nasdaq Stock Market LLC (“Nasdaq”) notified Avalo Therapeutics, Inc. (the “Company”) that for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”) and that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued inclusion on the Nasdaq Capital Market pursuant to Na”

Avalo Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 8, 2023, Nasdaq Stock Market LLC (“Nasdaq”) notified Avalo Therapeutics, Inc. (the “Company”) that for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”) and that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued inclusion on the Nasdaq Capital Market pursuant to Na”